1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "835621-11-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-I0678
    Regorafénib N-oxyde M2

    Drug Metabolite Cancer
    Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively.